Mono ADP-ribosylation inhibitors prevent inflammatory cytokine release in alveolar epithelial cells
- PMID: 18066713
- DOI: 10.1007/s11010-007-9667-3
Mono ADP-ribosylation inhibitors prevent inflammatory cytokine release in alveolar epithelial cells
Abstract
A549, a type II alveolar epithelial cell line stimulated with LPS (10 mug/ml), released high levels of the inflammatory cytokines IL-6 and IL-8. Here, we have investigated whether ADP-ribosylation inhibitors block the LPS-triggered cytokine release in epithelial cells. When coincubating A549 with LPS and meta-iodobenzylguanidine or novobiocin, selective arginine-dependent ART-inhibitors, the release of IL-6 and IL-8 was inhibited in a concentration-dependent manner. This effect has been linked with the presence of a functionally active arginine ADP-ribosylating enzyme on the cell surface. To this aim, we amplified by RT-PCR the ART1 transcript and identified four ADP-ribosylated proteins likely substrate for ART1. The mechanism behind the cytokine inhibition in epithelial cells seems to be correlated with the presence of ART1, which behaves as an essential positive regulator of inflammatory cytokines. This novel observation indicates this enzyme as well as other novobiocin/MIBG sensitive ARTs as potential targets for the development of new therapeutic strategies.
Similar articles
-
Inhibition of arginine ADP-ribosyltransferase 1 reduces the expression of poly(ADP-ribose) polymerase-1 in colon carcinoma.Int J Mol Med. 2013 Jul;32(1):130-6. doi: 10.3892/ijmm.2013.1370. Epub 2013 May 8. Int J Mol Med. 2013. PMID: 23652727
-
Expression and selective up-regulation of toxin-related mono ADP-ribosyltransferases by pathogen-associated molecular patterns in alveolar epithelial cells.FEBS Lett. 2007 Sep 4;581(22):4199-204. doi: 10.1016/j.febslet.2007.07.061. Epub 2007 Aug 3. FEBS Lett. 2007. PMID: 17707376
-
Inhibition of mono-ADP-ribosyltransferase activity during the execution phase of apoptosis prevents apoptotic body formation.Arch Biochem Biophys. 2001 Mar 1;387(1):66-77. doi: 10.1006/abbi.2000.2215. Arch Biochem Biophys. 2001. PMID: 11368185
-
ADP-ribosylarginine hydrolases and ADP-ribosyltransferases. Partners in ADP-ribosylation cycles.Adv Exp Med Biol. 1997;419:25-33. doi: 10.1007/978-1-4419-8632-0_3. Adv Exp Med Biol. 1997. PMID: 9193633 Review.
-
Characterization of glycosylphosphatidylinositiol-anchored, secreted, and intracellular vertebrate mono-ADP-ribosyltransferases.Annu Rev Nutr. 1999;19:485-509. doi: 10.1146/annurev.nutr.19.1.485. Annu Rev Nutr. 1999. PMID: 10448534 Review.
Cited by
-
TiPARP forms nuclear condensates to degrade HIF-1α and suppress tumorigenesis.Proc Natl Acad Sci U S A. 2020 Jun 16;117(24):13447-13456. doi: 10.1073/pnas.1921815117. Epub 2020 Jun 1. Proc Natl Acad Sci U S A. 2020. PMID: 32482854 Free PMC article.
-
ART1 knockdown decreases the IL-6-induced proliferation of colorectal cancer cells.BMC Cancer. 2024 Mar 19;24(1):354. doi: 10.1186/s12885-024-12120-0. BMC Cancer. 2024. PMID: 38504172 Free PMC article.
-
Mono-ADP-ribosylation sites of human CD73 inhibit its adenosine-generating enzymatic activity.Purinergic Signal. 2022 Mar;18(1):115-121. doi: 10.1007/s11302-021-09832-4. Epub 2021 Dec 27. Purinergic Signal. 2022. PMID: 34961895 Free PMC article.
-
Arginine ADP-ribosyltransferase 1 promotes angiogenesis in colorectal cancer via the PI3K/Akt pathway.Int J Mol Med. 2016 Mar;37(3):734-42. doi: 10.3892/ijmm.2016.2473. Epub 2016 Jan 29. Int J Mol Med. 2016. PMID: 26847718 Free PMC article.
-
Side chain specificity of ADP-ribosylation by a sirtuin.FEBS J. 2009 Dec;276(23):7159-76. doi: 10.1111/j.1742-4658.2009.07427.x. Epub 2009 Nov 6. FEBS J. 2009. PMID: 19895577 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources